Current AHA guidelines call for healthy Americans to bring LDL below 100 milligrams per deciliter (mg/dL) of blood, while ...

Many adults with high LDL (bad) cholesterol resign themselves to taking a statin drug when no other lifestyle changes will work—and in most cases rightly so, since the evidence is strong for ...

The FDA has approved Zepbound, a weight-loss medication, as the first drug treatment for moderate to severe obstructive sleep ...

Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

FDA approves Zepbound for sleep apnoea, a weight-loss medication that improves OSA symptoms in obese patients.

U.S. regulators have approved the first drug treatment for sleep apnea, allowing the use of a weight-loss medication to ...

The Scottish Medicines Consortium (SMC) has rejected Daiichi Sankyo’s new cholesterol-lowering drug Nilemdo for use by NHS Scotland, saying the evidence backing the drug isn’t strong enough.

"This breakthrough is a big step forward in developing new malaria treatments," Yu said. "By focusing on PfNCR1, scientists could develop drugs that the parasite finds difficult to develop resistance ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.